Manufacture

Creating more efficient preclinical processes could streamline the route to market for valuable therapies.

How pooled cell populations helped accelerate COVID-19 vaccine development – and what that means for the therapeutics of the future.

It’s time to celebrate The Medicine Maker annual Innovation Awards! Here, we showcase the top technologies released during 2021.

A team at the University of Bath have found a more efficient way to produce drugs using a catalyst powered by 420 nanometer blue light.

A whistle-stop tour of the mechanisms, benefits, manufacturing challenges, and clinical potential of CAR T cells, TCR T cells, TILs, and NK cells.

Joe Sinclair gives his view on how to be successful with oncolytic virotherapy.

Watch our video interview with We interview Joe Healey, CEO and Co-Founder of NanoSyrinx.

We interview Tamas Masztis, Senior Director, Cell Therapy Supply Chain for Europe, Kite, a Gilead Company.

We interview Sharon Brownlow from the Cell & Gene Therapy Catapult about her career and the top trends in cell therapy.

The latest issue of The Bioprocess Curator included a lot of interesting news about vaccines. In case you missed it, here's some of the top stories.